Your browser doesn't support javascript.
loading
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties.
Paranjape, A N; Soundararajan, R; Werden, S J; Joseph, R; Taube, J H; Liu, H; Rodriguez-Canales, J; Sphyris, N; Wistuba, I; Miura, N; Dhillon, J; Mahajan, N; Mahajan, K; Chang, J T; Ittmann, M; Maity, S N; Logothetis, C; Tang, D G; Mani, S A.
Afiliação
  • Paranjape AN; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Soundararajan R; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Werden SJ; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Joseph R; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Taube JH; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Liu H; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Rodriguez-Canales J; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Sphyris N; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Wistuba I; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Miura N; Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Dhillon J; Department of Oncological Sciences, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA.
  • Mahajan N; Department of Oncological Sciences, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA.
  • Mahajan K; Department of Oncological Sciences, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA.
  • Chang JT; Department of Integrative Biology and Pharmacology, School of Medicine, School of Biomedical Informatics, UT Health Sciences Center at Houston, Houston, TX, USA.
  • Ittmann M; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
  • Maity SN; Department of Genitourinary Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Logothetis C; Department of Genitourinary Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.
  • Tang DG; Department of Molecular Carcinogenesis, Science Park, UT MD Anderson Cancer Center, Smithville, TX, USA.
  • Mani SA; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
Oncogene ; 35(46): 5963-5976, 2016 11 17.
Article em En | MEDLINE | ID: mdl-26804168
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Células-Tronco Neoplásicas / Resistencia a Medicamentos Antineoplásicos / Epitélio / Fatores de Transcrição Forkhead Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Células-Tronco Neoplásicas / Resistencia a Medicamentos Antineoplásicos / Epitélio / Fatores de Transcrição Forkhead Idioma: En Ano de publicação: 2016 Tipo de documento: Article